Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Hamilton Lane Fiscal Q3 2026 Earnings Call - Evergreen-fueled fee growth and Guardian partnership set to boost revenue next quarter
Hamilton Lane turned in another quarter of momentum driven by its Evergreen platform and specialized funds, while a newly closed strategic partnership with Guardian promises an immediate capital and f...
- Total asset footprint exceeded $1 trillion at quarter end, up 6% year over year.
- AUM reached $146 billion, an 8% increase year over year; AUA was $871 billion, up 6% year over year.
- Fee-earning AUM was $79.1 billion, up $8.1 billion or 11% versus prior year; specialized funds account for $38.1 billion, up 22% year over year.
- +12 more takeaways
CorVel Corporation Q3 2025 Earnings Call - AI-driven efficiency and tech pivot offset slowing top-line growth
CorVel reported modest December-quarter results, with nine months revenue of $710 million, up 7% year over year, and quarter revenue of $236 million, up 3% from the prior-year quarter. Fiscal year to ...
- Nine months revenue was $710 million, up 7% versus $664 million a year earlier; December quarter revenue was $236 million, up 3% year over year.
- Earnings per share rose 16% year to date to $1.53, and quarterly EPS was $0.47, a 2% increase over prior-year quarter after adjusting for the 3-for-1 stock split.
- Net income for the December quarter was $24.1 million, slightly above $23.8 million in the prior-year quarter.
- +11 more takeaways
Spire Energy Fiscal Q1 2026 Earnings Call - Reaffirmed EPS Guidance as Tennessee Close Nears and Storage Sale Extends into Quarter
Spire reported a tidy beat in Q1 with adjusted EPS of $1.77 versus $1.34 a year ago, driven by utility rate changes, solid operations during Winter Storm Fern, and contributions from marketing and mid...
- Adjusted EPS for Q1 was $1.77 versus $1.34 in prior year, equivalent to $108 million of adjusted earnings.
- Gas utilities segment drove results with $104 million in earnings, up over 33% year over year, helped by new Missouri rates and higher margins under Alabama's RSE.
- Marketing earned $4.5 million, up $2.3 million, benefiting from increased portfolio optimization opportunities during volatile January markets.
- +12 more takeaways
Pfizer Fourth Quarter 2025 Earnings Call - VESPER-3 Validates PF-3944 Monthly GLP-1, Bolstering Obesity Platform
Pfizer closed 2025 with solid execution, beating adjusted EPS expectations and reaffirming 2026 guidance while navigating a sharp decline in COVID product revenue. The company reported FY revenues of ...
- VESPER-3 (PF-3944) met its two objectives: maintained robust weight loss switching from weekly to monthly dosing, and showed a favorable safety/tolerability profile when switching to a fourfold monthly dose.
- Week 28 placebo-adjusted weight loss in VESPER-3 was 10% for the low monthly dose and 12.3% for the medium monthly dose; model-based projections forecast ~16% placebo-adjusted loss for the planned high 9.6 mg monthly equivalent.
- VESPER-3 tolerability was comparable across weekly and monthly phases, predominantly mild to moderate GI adverse events, with only one instance each of severe nausea and vomiting across groups; no severe diarrhea reported and discontinuation rates were similar between phases.
- +13 more takeaways
Graphic Packaging Q4 2025 Earnings Call - CEO Prioritizes Inventory Cuts, $700-$800M 2026 FCF and $500M Debt Paydown
New CEO Robbert Rietbroek opened with a 30-day assessment and a clear reset: focus on operational fixes, tighter capex discipline, faster commercialization of innovation, and aggressive inventory redu...
- New CEO Robbert Rietbroek is running a 90-day review, emphasizing operational fixes, cost discipline, and faster commercialization of innovation after 30 days on the job.
- 2025 results: net sales ~$8.6 billion, adjusted EBITDA approximately $1.4 billion, fourth quarter adjusted EBITDA $311 million, adjusted EPS $1.80, ending net leverage 3.8x.
- 2026 guidance: net sales $8.4 billion to $8.6 billion, adjusted EBITDA guidance range $1.25 billion to $1.5 billion, normalized $1.2 billion to $1.4 billion, adjusted EPS $0.75 to $1.15.
- +12 more takeaways
Enterprise Products Partners Q4 2025 Earnings Call - Record $2.7B EBITDA; modest 2026, 10%+ growth expected in 2027 as NGL export and Permian ramps
Enterprise closed 2025 with a headline number investors love, a record fourth quarter adjusted EBITDA of $2.7 billion and a record near-$10 billion year for adjusted EBITDA. Management credited a stri...
- Record Q4 adjusted EBITDA of $2.7 billion, surpassing prior record, and near $10 billion adjusted EBITDA for full-year 2025.
- Net income attributable to common unit holders was $1.6 billion, or $0.75 per common unit, for Q4 2025.
- Adjusted cash flow from operations before working capital grew 5% to $2.4 billion in Q4 and reached a record $8.7 billion for 2025.
- +16 more takeaways
Patria Q4 2025 Earnings Call - Record Fundraising and Strategic M&A Push Fee-Earning AUM Toward $70B Goal
Patria closed 2025 with force, reporting a record $7.7 billion of organic fundraising, fee-related earnings of $203 million and distributable earnings of $200.9 million. Fee-earning AUM rose 24% year ...
- Record organic fundraising of $7.7 billion in 2025, well above the initial $6.0 billion target and the revised $6.6 billion midyear target.
- Fee-earning AUM ended Q4 at $40.8 billion, up 24% year over year; pro forma for announced acquisitions it is about $47.4 billion.
- Fee-related earnings (FRE) were $202.5 million for 2025, up 19% year over year, with Q4 FRE of $64.2 million and a Q4 FRE margin of roughly 63.6%.
- +13 more takeaways
ITW Q4 2025 Earnings Call - CBI and Enterprise Initiatives Push Margins to Record Levels, Guiding for Continued Expansion
ITW closed 2025 with a clean, operationally driven finish. Q4 total revenue rose 4.1% with organic up 1.3%, GAAP EPS improved 7% to $2.72, and companywide segment margins hit record levels as enterpri...
- Q4 total revenue grew 4.1%, comprised of organic growth of 1.3%, FX tailwind of 2.5%, and 0.3% from acquisitions.
- GAAP EPS in Q4 rose 7% to $2.72, and operating income was $1.1 billion, up 5% year over year.
- Companywide segment operating margin reached 27.7% in Q4, a 120 basis point improvement, with enterprise initiatives contributing roughly 140 basis points to that gain.
- +12 more takeaways
Ball Corporation Q4 2025 Earnings Call - Record EPS and FCF, 2026 Guidance Targets 10%+ Comparable EPS Despite $35M Headwinds
Ball closed out 2025 with one of its strongest years ever, reporting record comparable diluted EPS of $3.57 and record adjusted free cash flow of $956 million while returning $1.54 billion to sharehol...
- Record results: Comparable diluted EPS of $3.57 in 2025, up 13% year over year, and adjusted free cash flow of $956 million, a 2.4x increase versus 2024.
- Shareholder returns: Ball returned $1.54 billion in 2025 via $1.32 billion of buybacks and dividends; management plans at least $600 million of share repurchases in 2026, targeting 4% to 6% of shares annually.
- 2026 guidance: Company targets 10% plus comparable diluted EPS growth, free cash flow greater than $900 million, capex roughly in line with GAAP depreciation and amortization, and full year interest expense about $320 million.
- +12 more takeaways
Willis Towers Watson Q4 2025 Earnings Call - Margin expansion and strategic acquisitions drive 2026 momentum
WTW closed 2025 with steady organic growth and clear margin progress, reporting 6% organic growth in Q4 and 5% for the full year, adjusted operating margin up 130 basis points to 25.2% for the year, a...
- Q4 organic revenue growth was 6%, full year organic growth 5%, consistent with the company’s mid-single-digit target.
- Adjusted operating margin expanded 130 basis points year-over-year to 25.2% for FY2025; Q4 adjusted operating margin was 36.9%, up 80 basis points versus prior year.
- Adjusted diluted EPS was $17.08 for the year and $8.12 in Q4; excluding TRANZACT’s prior contribution, EPS rose about 13% year-over-year.
- +12 more takeaways